LEP and breast carcinoma: Accordingly, CAF-derived leptin promotes malignant behaviors of breast cancer cells, in addition to secreting factors, which stimulate reprogramming of adjacent CAFs to produce more leptin and further amplify leptin signaling in cancer cells [131].